Table 4.
Study measures.
|
|
Eligibility verification | Baseline survey | Monthly surveys | EMAsa | Adverse outcomes survey | |||||||||||||||||
|
|
|
|
#1 | #2 | #3 | #4 | #5 | #6 |
|
|
||||||||||||
| Inclusion and exclusion questions | ✓ |
|
|
|
|
|
|
|
|
|
||||||||||||
| Contact information | ✓ |
|
|
|
|
|
|
|
|
|
||||||||||||
| Demographics | ✓ | ✓ |
|
|
|
|
|
|
|
|
||||||||||||
| Social determinants of health |
|
✓ |
|
|
|
|
|
|
|
|
||||||||||||
| Technology access and acceptability | ||||||||||||||||||||||
|
|
Smartphone or tablet access | ✓ | ✓ |
|
|
|
|
|
|
|
|
|||||||||||
|
|
Internet or cellular data access | ✓ | ✓ |
|
|
|
|
|
|
|
|
|||||||||||
|
|
Wearables acceptability |
|
|
✓ |
|
|
|
|
✓ |
|
|
|||||||||||
| COVID-19 information | ||||||||||||||||||||||
|
|
COVID-19 testing | ✓ |
|
|
|
|
|
|
✓ |
|
|
|||||||||||
|
|
COVID-19 vaccination | ✓ |
|
|
|
|
|
|
✓ |
|
|
|||||||||||
|
|
COVID-19 symptoms |
|
✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
|
|||||||||||
|
|
COVID-19 medications |
|
✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
|
|||||||||||
| Medical information | ||||||||||||||||||||||
|
|
Concomitant medications |
|
✓ |
|
|
|
|
|
|
|
|
|||||||||||
|
|
Pregnancy and menstrual cycle |
|
✓ |
|
|
|
|
|
|
|
|
|||||||||||
|
|
Disability |
|
✓ |
|
|
|
|
|
|
|
|
|||||||||||
|
|
Existing and new health conditions |
|
✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
|
|
|||||||||||
|
|
Inpatient or outpatient care |
|
✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
|
✓ | |||||||||||
|
|
Adverse events |
|
|
|
|
|
|
|
✓ |
|
✓ | |||||||||||
| Risk and protective factors | ||||||||||||||||||||||
|
|
Body measurements |
|
✓ |
|
|
|
|
|
|
|
|
|||||||||||
|
|
Fruit and vegetable intake |
|
✓ |
|
|
|
|
|
|
|
|
|||||||||||
|
|
Physical activity |
|
✓ |
|
|
|
|
|
|
|
|
|||||||||||
|
|
Tobacco use |
|
✓ |
|
|
|
|
|
|
|
|
|||||||||||
|
|
Alcohol consumption |
|
✓ |
|
|
|
|
|
|
|
|
|||||||||||
|
|
Marijuana use |
|
✓ |
|
|
|
|
|
|
|
|
|||||||||||
|
|
Prescription and illicit drugs use |
|
✓ |
|
|
|
|
|
|
|
|
|||||||||||
| Patient-reported outcomes | ||||||||||||||||||||||
|
|
General health |
|
✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
|
|
|||||||||||
|
|
Perceived health change |
|
✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
|
|
|||||||||||
|
|
EQ-5D-5L health statusb |
|
✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
|
|
|||||||||||
|
|
EQ-VASc |
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
|
PROMISd-29 profile version 2.1 health-related quality of lifed |
|
✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
|
|
|||||||||||
|
|
PROMIS cognitive function version 2.0 (short form 8a) |
|
✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
|
|
|||||||||||
|
|
PROMIS dyspnea severity version 1.0 (short form 10a) |
|
✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
|
|
|||||||||||
aEMA: ecological momentary assessment.
bEQ-5D-5L: EurQol 5 domains, 5 levels. Captures 5 health dimensions: mobility, self-care, usual activities, pain or discomfort, and anxiety or depression.
cEQ-VAS: EurQol visual analog scale. Captures 7 domains: physical function, anxiety, depression, fatigue, sleep disturbance, ability to participate in social roles and activities, and pain interference, in addition to pain intensity.
dPROMIS: Patient-reported outcomes measurement information system.